Securian Asset Management, Inc Exelixis, Inc. Transaction History

Securian Asset Management, Inc

$3.39 Billion
Q4 2024

A detailed history of Securian Asset Management, Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Securian Asset Management, Inc holds 21,589 shares of EXEL stock, worth $801,599. This represents 0.02% of its overall portfolio holdings.

Number of Shares

21,589

Previous 22,181 2.67%

Holding current value

$801,599

Previous $575,000 24.87%

% of portfolio

0.02%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$25.39 - $36.46 $15,030 - $21,584	-592 Reduced 2.67%	21,589 $718,000
Q3 2024 Nov 13, 2024	SELL	$21.96 - $27.6 $23,079 - $29,007	-1,051 Reduced 4.52%	22,181 $575,000
Q2 2024 Jul 15, 2024	SELL	$20.34 - $23.73 $34,598 - $40,364	-1,701 Reduced 6.82%	23,232 $522,000
Q1 2024 Apr 26, 2024	SELL	$20.17 - $23.93 $26,422 - $31,348	-1,310 Reduced 4.99%	24,933 $591,000
Q4 2023 Feb 08, 2024	SELL	$19.25 - $24.13 $13,917 - $17,445	-723 Reduced 2.68%	26,243 $629,000
Q3 2023 Oct 30, 2023	SELL	$19.04 - $22.74 $38,879 - $46,435	-2,042 Reduced 7.04%	26,966 $589,000
Q2 2023 Aug 07, 2023	SELL	$18.17 - $20.48 $9,212 - $10,383	-507 Reduced 1.72%	29,008 $554,000
Q1 2023 Apr 27, 2023	SELL	$16.3 - $19.41 $2,053 - $2,445	-126 Reduced 0.43%	29,515 $572,000
Q4 2022 Feb 02, 2023	BUY	$14.96 - $17.39 $3,784 - $4,399	253 Added 0.86%	29,641 $475,000
Q3 2022 Oct 28, 2022	BUY	$15.68 - $22.27 $2,320 - $3,295	148 Added 0.51%	29,388 $461,000
Q2 2022 Aug 04, 2022	BUY	$17.44 - $23.16 $14,841 - $19,709	851 Added 3.0%	29,240 $609,000
Q1 2022 May 03, 2022	BUY	$17.03 - $22.67 $2,299 - $3,060	135 Added 0.48%	28,389 $644,000
Q3 2021 Nov 08, 2021	SELL	$16.3 - $21.14 $8,916 - $11,563	-547 Reduced 1.9%	28,254 $597,000
Q2 2021 Aug 10, 2021	SELL	$17.95 - $25.56 $10,913 - $15,540	-608 Reduced 2.07%	28,801 $525,000
Q4 2020 Feb 08, 2021	SELL	$18.39 - $24.8 $11,015 - $14,855	-599 Reduced 2.0%	29,409 $590,000
Q3 2020 Nov 04, 2020	SELL	$20.67 - $26.94 $21,703 - $28,287	-1,050 Reduced 3.38%	30,008 $734,000
Q2 2020 Aug 06, 2020	SELL	$16.46 - $27.42 $2,222 - $3,701	-135 Reduced 0.43%	31,058 $737,000
Q4 2019 Feb 04, 2020	SELL	$15.15 - $18.89 $42,495 - $52,986	-2,805 Reduced 8.25%	31,193 $550,000
Q3 2019 Nov 12, 2019	SELL	$17.68 - $22.65 $39,691 - $50,849	-2,245 Reduced 6.19%	33,998 $601,000
Q2 2019 Aug 05, 2019	SELL	$18.93 - $24.75 $4,770 - $6,237	-252 Reduced 0.69%	36,243 $775,000
Q3 2018 Oct 26, 2018	BUY	$15.87 - $22.4 $180,997 - $255,471	11,405 Added 45.46%	36,495 $647,000
Q2 2018 Aug 09, 2018	BUY	$18.56 - $22.45 $465,670 - $563,270	25,090 New	25,090 $540,000

Others Institutions Holding EXEL

# of Institutions

564

Shares Held

251M

Call Options Held

1.45M

Put Options Held

1.13M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Securian Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Securian Asset Management, Inc with notifications on news.

Account

Securian Asset Management, Inc Exelixis, Inc. Transaction History